INSULET CORPORATION (PODD) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 18.90M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 3.17B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $18.90M | (m) | (m) | (m) | $3.17B | (m) |
| 2026-03-31 | (m) | (m) | $18.60M | (m) | (m) | (m) | $2.99B | (m) |
| 2025-12-31 | (m) | (m) | $18.40M | (m) | (m) | (m) | $3.19B | (m) |
| 2025-09-30 | (m) | (m) | $79.90M | (m) | (m) | (m) | $3.03B | (m) |
| 2025-06-30 | (m) | (m) | $460.70M | (m) | (m) | (m) | $3.47B | (m) |
| 2025-03-31 | (m) | (m) | $83.10M | (m) | (m) | (m) | $3.52B | (m) |
| 2024-12-31 | (m) | (m) | $83.80M | (m) | (m) | (m) | $3.09B | (m) |
| 2024-09-30 | (m) | (m) | $42.00M | (m) | (m) | (m) | $3.03B | (m) |
| 2024-06-30 | (m) | (m) | $37.90M | (m) | (m) | (m) | $2.88B | (m) |
| 2024-03-31 | (m) | (m) | $38.90M | (m) | (m) | (m) | $2.62B | (m) |
| 2023-12-31 | (m) | (m) | $49.40M | (m) | (m) | (m) | $2.59B | (m) |
| 2023-09-30 | (m) | (m) | $49.80M | (m) | (m) | (m) | $2.47B | (m) |
| 2023-06-30 | (m) | (m) | $29.20M | $1.37B | (m) | (m) | $2.39B | (m) |
| 2023-03-31 | (m) | (m) | $27.80M | $1.37B | (m) | (m) | $2.29B | (m) |
| 2022-12-31 | (m) | (m) | $27.50M | $1.37B | (m) | (m) | $2.25B | (m) |
| 2022-09-30 | (m) | (m) | $26.90M | $1.38B | (m) | (m) | $2.17B | (m) |
| 2022-06-30 | (m) | (m) | $26.30M | $1.39B | (m) | (m) | $2.11B | (m) |
| 2022-03-31 | (m) | (m) | $25.70M | $1.39B | (m) | (m) | $2.07B | (m) |
| 2021-12-31 | (m) | (m) | $25.10M | $1.25B | (m) | (m) | $2.05B | (m) |
| 2021-09-30 | (m) | (m) | $28.90M | $1.26B | (m) | $857.10M | $2.00B | (m) |
| 2021-06-30 | (m) | (m) | $20.90M | $1.24B | (m) | $872.10M | $1.92B | (m) |
| 2021-03-31 | (m) | (m) | $15.70M | $1.05B | (m) | $850.20M | $1.84B | (m) |
| 2020-12-31 | (m) | (m) | $15.60M | $1.04B | (m) | $947.60M | $1.87B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $921.50M | (m) | $896.70M | $1.71B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $910.20M | (m) | $844.40M | $1.63B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $899.00M | (m) | $321.60M | $1.11B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $887.90M | (m) | $376.10M | $1.14B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $985.77M | (m) | $605.50M | $1.27B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $607.35M | (m) | $309.75M | $977.72M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $599.60M | (m) | $316.37M | $952.61M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $591.98M | (m) | $288.95M | $928.74M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $584.49M | (m) | $289.84M | $886.31M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $577.12M | (m) | $299.79M | $838.86M | (m) |
| 2018-03-31 | (m) | (m) | $3.45M | $569.88M | (m) | $352.00M | $829.76M | (m) |
| 2017-12-31 | (m) | (m) | (m) | $566.17M | (m) | $440.06M | $816.74M | (m) |
| 2017-09-30 | (m) | (m) | (m) | $344.95M | (m) | $275.76M | $500.35M | (m) |
| 2017-06-30 | (m) | (m) | (m) | $340.84M | (m) | $258.61M | $459.33M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $336.76M | (m) | $254.03M | $444.96M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $332.77M | (m) | $298.57M | $456.65M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $328.96M | (m) | $282.69M | $453.20M | (m) |
| 2016-06-30 | (m) | (m) | (m) | $175.69M | (m) | $111.27M | $263.05M | (m) |
| 2016-03-31 | (m) | (m) | (m) | $173.68M | (m) | (m) | $254.77M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $171.70M | (m) | (m) | $275.13M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $173.87M | (m) | (m) | $293.12M | (m) |
| 2015-06-30 | (m) | (m) | (m) | $172.22M | (m) | (m) | $300.39M | (m) |
| 2015-03-31 | (m) | (m) | (m) | $170.59M | (m) | (m) | $305.72M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $168.99M | (m) | (m) | $302.16M | (m) |
| 2014-09-30 | (m) | (m) | (m) | $167.42M | (m) | (m) | $301.20M | (m) |
| 2014-06-30 | (m) | (m) | $23.87M | $165.87M | (m) | (m) | $325.33M | (m) |
| 2014-03-31 | (m) | (m) | (m) | $116.28M | (m) | (m) | $288.53M | (m) |
| 2013-12-31 | (m) | (m) | $0.00 | $113.65M | (m) | (m) | $287.95M | (m) |
| 2013-09-30 | (m) | (m) | $0.00 | $111.12M | (m) | (m) | $289.50M | (m) |
| 2013-06-30 | (m) | (m) | $0.00 | $108.67M | (m) | (m) | $286.15M | (m) |
| 2013-03-31 | (m) | (m) | $14.73M | $106.19M | (m) | (m) | $280.90M | (m) |
| 2012-12-31 | (m) | (m) | $14.43M | $103.73M | (m) | (m) | $198.06M | (m) |
| 2012-09-30 | (m) | (m) | $14.13M | $101.52M | (m) | (m) | $191.64M | (m) |
| 2012-06-30 | (m) | (m) | $13.85M | $99.38M | (m) | (m) | $191.94M | (m) |
| 2012-03-31 | (m) | (m) | (m) | $110.84M | (m) | (m) | $203.94M | (m) |
| 2011-12-31 | (m) | (m) | (m) | $108.54M | (m) | (m) | $209.58M | (m) |
| 2010-12-31 | (m) | (m) | (m) | $69.43M | (m) | (m) | $156.23M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |